1. Home
  2. SEPN vs KE Comparison

SEPN vs KE Comparison

Compare SEPN & KE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEPN
  • KE
  • Stock Information
  • Founded
  • SEPN 2022
  • KE 1961
  • Country
  • SEPN United States
  • KE United States
  • Employees
  • SEPN 75
  • KE N/A
  • Industry
  • SEPN
  • KE Electrical Products
  • Sector
  • SEPN
  • KE Technology
  • Exchange
  • SEPN NYSE
  • KE Nasdaq
  • Market Cap
  • SEPN 553.0M
  • KE 477.1M
  • IPO Year
  • SEPN 2024
  • KE N/A
  • Fundamental
  • Price
  • SEPN $12.21
  • KE $18.26
  • Analyst Decision
  • SEPN Strong Buy
  • KE Buy
  • Analyst Count
  • SEPN 5
  • KE 5
  • Target Price
  • SEPN $26.75
  • KE $22.20
  • AVG Volume (30 Days)
  • SEPN 222.3K
  • KE 100.3K
  • Earning Date
  • SEPN 08-15-2025
  • KE 08-13-2025
  • Dividend Yield
  • SEPN N/A
  • KE N/A
  • EPS Growth
  • SEPN N/A
  • KE N/A
  • EPS
  • SEPN N/A
  • KE 0.71
  • Revenue
  • SEPN $977,000.00
  • KE $1,536,413,000.00
  • Revenue This Year
  • SEPN $3,429.67
  • KE N/A
  • Revenue Next Year
  • SEPN N/A
  • KE N/A
  • P/E Ratio
  • SEPN N/A
  • KE $25.71
  • Revenue Growth
  • SEPN 108.76
  • KE N/A
  • 52 Week Low
  • SEPN $4.17
  • KE $12.41
  • 52 Week High
  • SEPN $28.99
  • KE $23.85
  • Technical
  • Relative Strength Index (RSI)
  • SEPN N/A
  • KE 35.24
  • Support Level
  • SEPN N/A
  • KE $18.53
  • Resistance Level
  • SEPN N/A
  • KE $19.69
  • Average True Range (ATR)
  • SEPN 0.00
  • KE 0.45
  • MACD
  • SEPN 0.00
  • KE -0.15
  • Stochastic Oscillator
  • SEPN 0.00
  • KE 12.15

About SEPN SEPTERNA INC

Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.

About KE Kimball Electronics Inc.

Kimball Electronics Inc is a contract electronic manufacturing services company. The company is engaged in producing durable electronics for the automotive, medical, industrial, and public safety end markets. The company's engineering, manufacturing, and supply chain services utilize common production and support capabilities. It is also engaged in producing safety-critical electronic assemblies for its automotive customers. Geographically, it has business units located in the United States, China, Mexico, Poland, Romania, and Thailand. The company derives maximum revenue from Mexico.

Share on Social Networks: